The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Bychkova A.E.

National Medical Research Center for Obstetrics, Gynecology and Perinatology named after academician V.I. Kulakov

Apolikhina I.A.

National Medical Research Center for Obstetrics, Gynecology and Perinatology named after academician V.I. Kulakov

Life after

Authors:

Bychkova A.E., Apolikhina I.A.

More about the authors

Journal: Non Nocere. New Therapeutic Journal. 2026;(3): 54‑57

Read: 99 times

To cite this article:

Bychkova AE, Apolikhina IA. Life after. Non Nocere. New Therapeutic Journal. 2026;(3):54‑57. (In Russ.)

References:

  1. Wild CP, Weiderpass E, Stewart BW, editors. World Cancer Report: Cancer research for cancer prevention. Lyon (FR): International Agency for Research on Cancer; 2020.
  2. Li Y, Song W, Gao P, et al. Global, regional, and national burden of breast, cervical, uterine, and ovarian cancer and their risk factors among women from 1990 to 2021, and projections to 2050: findings from the global burden of disease study 2021. BMC Cancer. 2025 Feb 24;25(1):330.  https://doi.org/10.1186/s12885-025-13741-9
  3. Zhang X, Zeng Q, Cai W, Ruan W. Trends of cervical cancer at global, regional, and national level: data from the Global Burden of Disease study 2019. BMC Public Health. 2021 May 12;21(1):894.  https://doi.org/10.1186/s12889-021-10907-5
  4. Malignant neoplasms in Russia in 2024 (incidence) / ed. HELL. Kaprina [and others]. – Moscow: MNIOI im. P.A. Herzen branch of the Federal State Budgetary Institution “National Medical Research Center of Radiology” of the Ministry of Health of Russia, 2025. – 178 p. : ill. – ISBN 978-5-85502-311-4. 
  5. National Cancer Institute, SEER Program. Cancer Stat Facts: Corpus Uteri Cancer [Electronic resource]. – 2024. (access date: 01/12/2026). https://seer.cancer.gov/statfacts/html/corp.html
  6. National Cancer Institute, SEER Program. Cancer Stat Facts: Cervix Uteri Cancer [Electronic resource]. – 2024 (access date: 01/12/2026). https://seer.cancer.gov/statfacts/html/cervix.html
  7. Doust J, Huguenin A, Hickey M. Genitourinary Syndrome of Menopause: Does Everyone Have It? Clin Obstet Gynecol. 2024 Mar 1;67(1):4-12.  https://doi.org/10.1097/GRF.0000000000000834
  8. Lang XL, Huang CC, Cui HY, Zhong HX, Shen MY, Zhao F. From physiology to psychology: An integrative review of menopausal syndrome. World J Psychiatry. 2025 Nov 19;15(11):108713. https://doi.org/10.5498/wjp.v15.i11.108713
  9. Cianci S, Tarascio M, Arcieri M, et al. Post Treatment Sexual Function and Quality of Life of Patients Affected by Cervical Cancer: A Systematic Review. Medicina (Kaunas). 2023 Apr 4;59(4):704.  https://doi.org/10.3390/medicina59040704
  10. Drugs for menopausal symptoms. Med Lett Drugs Ther. 2020 Aug 10;62(1604):124-128. Corrected and republished in: JAMA. 2021 Jun 15;325(23):2394-2395. https://doi.org/10.1001/jama.2020.15592
  11. Menopause and menopause in women: rubricator of clinical recommendations / Ministry of Health of the Russian Federation. – Electron. Dan. – 2025. – ID: 117_3 (date of access: 01/12/2026). https://cr.minzdrav.gov.ru/view-cr/117_3
  12. Kaufman MR, Ackerman AL, Amin KA, et al. The AUA/SUFU/AUGS Guideline on Genitourinary Syndrome of Menopause. J Urol. 2025 Sep;214(3):242-250.  https://doi.org/10.1097/JU.0000000000004589
  13. Cox P, Panay N. Vulvovaginal atrophy in women after cancer. Climacteric. 2019 Dec;22(6):565-571.  https://doi.org/10.1080/13697137.2019.1643180
  14. Faubion SS, Larkin LC, Stuenkel CA, et al. Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from The North American Menopause Society and The International Society for the Study of Women’s Sexual Health. Menopause. 2018 Jun;25(6):596-608.  https://doi.org/10.1097/GME.0000000000001121
  15. Pruthi S, Simon JA, Early AP. Current overview of the management of urogenital atrophy in women with breast cancer. Breast J. 2011 Jul-Aug;17(4):403-408.  https://doi.org/10.1111/j.1524-4741.2011.01089.x
  16. Chargari C, Tanderup K, Planchamp F, et al. ESGO/ESTRO quality indicators for radiation therapy of cervical cancer. Int J Gynecol Cancer. 2023 Jun 5;33(6):862-875.  https://doi.org/10.1136/ijgc-2022-004180
  17. Crandall CJ, Hovey KM, Andrews CA, et al. Breast cancer, endometrial cancer, and cardiovascular events in participants who used vaginal estrogen in the Women’s Health Initiative Observational Study. Menopause. 2018;25(1):11-20.  https://doi.org/10.1097/GME.0000000000000956
  18. Chambers LM, Herrmann A, Michener CM, Ferrando CA, Ricci S. Vaginal estrogen use for genitourinary symptoms in women with a history of uterine, cervical, or ovarian carcinoma. Int J Gynecol Cancer. 2020;30:515-524.  https://doi.org/10.1136/ijgc-2019-001034
  19. Farrell Am E. Genitourinary syndrome of menopause. Aust Fam Physician. 2017;46:481-484. 
  20. Apolikhina IA, Tarnaeva LA. Current trends in the prevention and treatment of genitourinary menopausal syndrome. Meditsinskiy sovet = Medical Council. 2023;(15):111-116. (In Russ.) https://doi.org/10.21518/ms2023-294
  21. Palacios S. Non-hormonal approaches for the treatment of vulvovaginal atrophy: the choice between hyaluronic acid and glycerin. Gynecol Endocrinol. 2020 Oct;36(10):847-848. Epub 2020 Sep2. https://doi.org/10.1080/09513590.2020.1815698
  22. Edwards D, Panay N. Treating vulvovaginal atrophy/genitourinary syndrome of menopause: how important is vaginal lubricant and moisturizer composition? Climacteric. 2016;19:151-161.  https://doi.org/10.3109/13697137.2015.1124259
  23. American Society of Plastic Surgeons. Plastic Surgery Statistics Report 2020. – 2020 (access date: 05/15/2022). https://www.plasticsurgery.org/documents/News/Statistics/2020/cosmetic-procedure-trends-2020.pdf
  24. Saljoughian M. Benefits and Risk of Facial Fillers. US Pharm. 2019;44:9-12. 
  25. Cho L, Kaunitz AM, Faubion SS, et al. Rethinking Menopausal Hormone Therapy: For Whom, What, When, and How Long? Circulation. 2023 Feb 14;147(7):597-610.  https://doi.org/10.1161/CIRCULATIONAHA.122.061559
  26. Mkrtchian L.S., Krikunova L.I., Bychkova A.E., et al. Quality of life of patients with cervical and uterine cancer after radical treatment and rehabilitation options using hyaluronic acid-based volume-forming agents. Research and Practical Medicine Journal. 2025;12(4):8-21. (In Russ.) https://doi.org/10.17709/2410-1893-2025-12-4-1
  27. Ramazanova M.O., Apolikhina I.A., Shershakova E.I. Modern problems and opportunities in the treatment of genitourinary syndrome of menopause in the context of medical science and technology development. Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2024;(5):24-31. (In Russ.) https://doi.org/10.18565/aig.2024.77

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.